Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited (CORXEL).…
Browsing: Pharma
Pacific Avenue Capital Partners (Pacific Avenue), a Los Angeles-headquartered private equity firm focused on corporate carve-outs and other complex transactions…
March 9, Everest Medicines (HKG: 1952) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by…
International Women’s Day: Why Menopause May Be a Missed Cardiovascular Risk Window As International Women’s Day prompts renewed focus on…
– First glucokinase-activator (GKA) approval outside mainland China – Approval supports a differentiated approach to Type 2 diabetes (T2D) management…
– Exhibition space fully secured prior to the show, reflecting strong exhibitor confidence in Northern Vietnam’s laboratory and scientific markets…
CanSino Biologics Inc. (688185.SH/06185.HK) announced that the Company has obtained the Notification of Approval of Supplemental Drug Application issued by…
12 February 2026, Modern Dental Group Limited (Modern Dental or the Group, HKG: 3600), a leading global dental prosthetic device provider,…
Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial…
Essex Bio-Technology Limited (EssexBio or the Company; HKG: 1061) today announces its successful participation in the 41st Asia-Pacific Academy of…
According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC)…
According to the disclosure of interests information released by the Hong Kong Stock Exchange, on 5 February, GIC Private Limited…
On February 6, Distinct Healthcare Holdings Limited (Distinct Healthcare or the Company, Stock Code: 2677.HK), a leading player in China’s…
Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment…
According to the disclosure of interests information released by the Hong Kong Stock Exchange, GIC Private Limited made its equity…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization…
Industry recognition for the third consecutive year reinforces AGFA HealthCare’s clinician-first commitment, and leadership in empowering connected, high-performance imaging environments…
Agreement Expands Access to Evonik’s CARE Brand Medical Grades in the U.S. and Canada Formerra, a leader in performance materials…
Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced…
Company reiterates focus on advancing ProLectin-M under an active FDA IND and progressing oxygen-transport programs for stroke and neurodegenerative disease…